MYL5 as a Novel Prognostic Marker is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study

<div>Prognostic analysis of MYL5 expression and immune infiltrate cells among different molecular subtypes of BRCA. We used the TIMER tool to analyze the correlation of MYL5 with B cell, M1 macrophage, M2 macrophage, tumor-associated macrophage (TAM), monocytes, and T cell exhaustion among BRCA (a), BRCA-Basal (b), BRCA-luminal (c), and BRCA-Her2 (d).</div>

The Breast Journal

fig6

Figure 6

Figure 6: MYL5 as a Novel Prognostic Marker is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study 